Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients
for ≥5 days were predicted to rapidly decrease viral loads, reduce the proportion of patients with detectable SARS‐CoV‐2 infection, and
Dosage, route, and timing of hydroxychloroquine and azithromycin were collected
This report led to widespread use of high-dose hydroxychloroquine either alone or with azithromycin
ResultsAmong 90 patients given hydroxychloroquine, 53 received concomitant azithromycin; 44 (48
Conclusion: Treatment of COVID-19 using a combination of hydroxychloroquine plus azithromycin was safe and was associated with a